Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

ClinicalTrials.gov ID: NCT07213778

Public ClinicalTrials.gov record NCT07213778. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related diseases after total knee replacement surgery compared to acetylsalicylic acid. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

Study identification

NCT ID
NCT07213778
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
2,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 24, 2025 (Actual)
Primary completion
May 17, 2027 (Estimated)
Completion
Jul 16, 2027 (Estimated)
Last update posted
Oct 22, 2026

2025 – 2027

United States locations

U.S. sites
38
U.S. states
17
U.S. cities
33
Facility City State ZIP Site status
Horizon Clinical Research La Mesa California 91942 Recruiting
Eisenhower Medical Center Rancho Mirage California 92270 Recruiting
CARI Clinical Trials Riverside California 92504 Recruiting
HCA HealthONE Centennial Englewood Colorado 80113 Recruiting
HCA HealthONE, HCA HealthONE Sky Ridge Lone Tree Colorado 80124 Recruiting
South Florida Joint Replacement Center Deerfield Beach Florida 33064 Recruiting
Delray Physician Care Center Delray Beach Florida 33445 Recruiting
Medical Research of Westchester - MPLUS Research Network Miami Florida 33165 Recruiting
Larkin Community Hospital South Miami South Miami Florida 33143 Recruiting
Phoenix Clinical Research Tamarac Florida 33321 Recruiting
Endeavor Health Skokie Illinois 60076 Recruiting
The Orthopaedic Research Foundation, Inc. Indianapolis Indiana 46278 Recruiting
NextStage Clinical Research, St. Francis Medical Park Wichita Kansas 67214 Recruiting
Velocity Clinical Research, Annapolis Annapolis Maryland 21401 Recruiting
Sinai Hospital of Baltimore, Inc. Baltimore Maryland 21215 Recruiting
Tufts Medical Center Boston Massachusetts 02111 Recruiting
Boston Medical Center Boston Massachusetts 02118 Recruiting
Holy Name Medical Center Teaneck New Jersey 07666 Recruiting
Northwell Orthopaedic Institute New York New York 10065 Recruiting
University of Rochester Medical Center Rochester New York 14623-5863 Recruiting
UBMD Orthopaedics and Sports Medicine Williamsville New York 14211 Recruiting
Atrium Health Musculoskeletal Institute and Sports Medicine Charlotte North Carolina 28211 Recruiting
Duke University Health System (Duke Health), Duke University Hospital Durham North Carolina 27710 Recruiting
Eximia Equihealth Research-Raleigh. LLC Raleigh North Carolina 27612 Recruiting
The Vein and Vascular Center at Raleigh Radiology Raleigh North Carolina 27612 Recruiting
Coastal Vascular Institute, PA Wilmington North Carolina 28401 Recruiting
University of Cincinnati Cincinnati Ohio 45267 Recruiting
The Ohio State University Wexner Medical Center Columbus Ohio 43210 Recruiting
Ohio Clinical Trials Columbus Ohio 43212 Recruiting
Penn State Health Milton S. Hershey Medical Center Hershey Pennsylvania 17033 Recruiting
University of Pittsburgh Pittsburgh Pennsylvania 15213-3108 Recruiting
HD Research - Memorial Hermann Village Houston Texas 77043 Completed
NextStage Clinical Research, All American Orthopedics and Sports Medicine Houston Texas 77058 Recruiting
Flourish Research - San Antonio (Formerly Clinical Trials of Texas) San Antonio Texas 78229 Recruiting
Endeavor Clinical Trials San Antonio Texas 78240 Withdrawn
DRx Clinical Research, LLC St. George Utah 84770 Recruiting
Carilion Clinic Roanoke Virginia 24015 Recruiting
Spokane Joint Replacement Center Spokane Washington 99218 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07213778, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07213778 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →